Lina Merjaneh
Overview
Explore the profile of Lina Merjaneh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brady R, Jensen E, Rigdon J, A Crimmins N, Mallon D, Dolan L, et al.
Pediatr Diabetes
. 2025 Jan;
2023.
PMID: 39845332
Aims: Celiac disease (CD) in adults with type 1 diabetes has been associated with increased cardiovascular risk and the earlier occurrence of diabetes-associated complications. In the Search for Diabetes in...
2.
Merjaneh L, Sidhaye A, Vu P, Heltshe S, Goss C, Flume P, et al.
J Cyst Fibros
. 2023 Jul;
22(5):868-874.
PMID: 37394317
Background: Hyperglycemia could affect treatment response during cystic fibrosis (CF) exacerbations. We aimed to evaluate the prevalence and associations of hyperglycemia with exacerbation outcomes. We also evaluated feasibility of continuous...
3.
Merjaneh L, Dolan L, Suerken C, DAgostino Jr R, Imperatore G, Saydah S, et al.
Pediatr Diabetes
. 2022 Sep;
23(7):1027-1037.
PMID: 36054435
To assess changes in diabetes autoantibodies (DAs) over time in children and young adults with diabetes and determine whether observed changes were associated with demographic characteristics, clinical parameters and diabetes...
4.
Davis C, Faino A, Onchiri F, Gibson R, Merjaneh L, Ramsey B, et al.
Ann Am Thorac Soc
. 2022 Aug;
20(1):75-82.
PMID: 36044723
Pulmonary exacerbation (PEx) events contribute to lung function decline in people with cystic fibrosis (CF). CF Foundation PEx guidelines note that a short course of systemic corticosteroids may offer benefit...
5.
Reid L, Mendoza J, Merchant A, Geraci M, Reboussin B, Malik F, et al.
Pediatr Diabetes
. 2022 Jun;
23(7):982-990.
PMID: 35752872
Objective: To examine the association between household food insecurity (HFI), glycemic control, severe hypoglycemia and diabetic ketoacidosis (DKA) among youth and young adults (YYA) with youth-onset type 2 diabetes. Research...
6.
Merjaneh L, Hasan S, Kasim N, Ode K
J Clin Transl Endocrinol
. 2021 Dec;
27:100286.
PMID: 34917484
The development and introduction of modulator therapies have completely shifted the paradigm for the treatment of cystic fibrosis (CF). Highly effective modulator therapies have driven marked improvements in lung function,...
7.
Darukhanavala A, Merjaneh L, Mason K, Le T
J Clin Transl Endocrinol
. 2021 Dec;
26:100280.
PMID: 34917482
Eating disorders and disturbed body image have been reported in individuals with cystic fibrosis (CF) and may contribute to poor weight gain, reduced lung function and increased mortality. CF individuals...
8.
Roe A, Merjaneh L, Oxman R, Hughan K
J Clin Transl Endocrinol
. 2021 Dec;
26:100277.
PMID: 34849351
As females with cystic fibrosis (CF) increasingly reach their reproductive years, gynecologic issues have become an important area of clinical care and research. First, females with CF may have disease-specific...
9.
10.
Merjaneh L, Toprak D, McNamara S, Nay L, Sullivan E, Rosenfeld M
Endocrinol Diabetes Metab
. 2021 Apr;
4(2):e00208.
PMID: 33855211
Background: Hyperglycaemia may contribute to failure to recover from pulmonary exacerbations in cystic fibrosis (CF). We aimed to evaluate the prevalence and mechanism of hyperglycaemia during and post-exacerbations. Methods: Nine...